News Center

2018year

Categories:Development
Author:
Origin:
Time of issue:2018-09-14

Information

More than 200 patients were enrolled.
The world's first CAR-T treatment of HIV and obtained invention patent authorization.
The GMP industrial base was put into use.

Previous : 2019year

Next : 2017year

Previous : 2019year

Next : 2017year

RELATED NEWS

Hubei Meilin Pharmaceutical Co., Ltd. was completed and put into production

News analysis: Where did you go to find the new crown drug?

End of the pilot, innovation and start again

The list of key monitoring drugs may be adjusted every two years, and 30 varieties will be included

Offline supervision of pharmacies and cross-departmental “joint inspections” in many places

R&D internal volume and admission rate is only 25%! How to reconstruct the pattern of innovative drugs under the New Deal?

More than 1,600 public hospitals in China's Internet hospitals become the main force for construction

The Differential Development of Specialty Pharmacies in China and America

New regulations for long prescriptions! Biological agents are not excluded, and the issuance of long prescriptions shall not be affected on the grounds of cost control and the proportion of medicines!

Exhibition News | Zhisaila·Hospital Intelligent Robots at the 39th Zhongyuan Medical Equipment Exhibition, the highlights are different

Links

CFDA

All links

Business Email：hbmlyy@merriclin.cn HR Email：hr@merriclin.cn

Company address：No. 8 Heping Road, Economic Development Zone, Yunmeng County, Xiaogan, Hubei Postal code：432500 This website supports IPV6

Filing information：鄂公网安备42092300000000号鄂ICP备20010943号-1 《Internet information service qualification certificate》No.(E) - non operating-2020-0023

Operation information: the website has been running for 00001 days. It is recommended to use the browser based on chromium core to browse the website at a resolution of no less than 1920 * 1280px to obtain good browsing effect.

Merriclin Official Website

Merriclin WeChat Official